Drug profile · INN
pemetrexed sodium
PEMETREXED
pemetrexed sodium (PEMETREXED) is a thymidylate synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — pemetrexed sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 4
- Programs
- 116
- Data quality
- 0.89
Quick answer
pemetrexed sodium (PEMETREXED) is a thymidylate synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thymidylate synthase inhibitor
Primary target: Dihydrofolate reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11612662
Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
granted -
US 10736969
Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
granted -
EP 2882753
VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON
granted -
US 8952153
One pot process for preparing pemetrexed disodium
granted
Frequently asked questions
What is pemetrexed sodium?
pemetrexed sodium (PEMETREXED) is a thymidylate synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pemetrexed sodium?
PEMETREXED is a marketed brand name for pemetrexed sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemetrexed sodium?
pemetrexed sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.